Obesity Queue Database
1 other identifier
observational
5,000
1 country
1
Brief Summary
To establish an obesity specific disease cohort database and form a special disease cohort, so as to provide guarantee for carrying out high-quality real-world clinical research and clinical research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
April 30, 2024
April 1, 2024
5.3 years
March 31, 2024
April 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
MRI-PDFF intraperitoneal fat content, fasting and postprandial blood glucose, insulin, C-peptide, glycated hemoglobin, body weight, waist circumference, hip circumference
For a specialized outpatient clinic for obesity, follow-ups should be conducted at 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. During the trial period and the post-trial observation period, relevant safety indicators must be documented, analyzed statistically, and reported.
5 years
Secondary Outcomes (1)
Intestinal flora components, glucagon, gastrointestinal hormones GLP-1 and GIP, inflammatory immune indicators, etc
5 years
Interventions
Observational studies do not involve intervention
Eligibility Criteria
Patients with obesity, aged 18-75 years, who met the diagnostic criteria for simple obesity and did not participate in any drug clinical trials within 3 months prior to inclusion.
You may qualify if:
- Patients aged 18-75 years with simple obesity. Simple obesity diagnosis criteria: meet one of the following conditions
- BMI≥25 kg/m2
- Waist circumference for male/female ≥90/80 cm
- Waist-to-hip ratio: 0.9 (male); 0.85 (female)
You may not qualify if:
- Patients aged 18-75 years with simple obesity. Simple obesity diagnosis criteria: meet one of the following conditions
- BMI≥25 kg/m2
- Waist circumference for male/female ≥90/80 cm
- Waist-to-hip ratio: 0.9 (male); 0.85 (female)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
Study Sites (1)
Renji Hospital, Shanghai Jiao Tong University, School of Medicine
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2024
First Posted
April 30, 2024
Study Start
September 1, 2023
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share